Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases

Between 2% and 6% of epithelial ovarian cancer (EOC) patients develop brain metastases (brain mets), which are incurable and invariably result in death. This poor outcome is associated with a lack of established guidelines for the detection and treatment of brain mets in EOC patients. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pejovic, Tanja, Abate, Pierre-Valérien, Ma, Hongli, Thiessen, Jaclyn, Corless, Christopher L., Peterson, Abigail, Allard-Chamard, Hugues, Labrie, Marilyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174542/
https://www.ncbi.nlm.nih.gov/pubmed/35692807
http://dx.doi.org/10.3389/fonc.2022.903806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174542/
https://www.ncbi.nlm.nih.gov/pubmed/35692807
http://dx.doi.org/10.3389/fonc.2022.903806

Ejemplares similares